Trial Profile
Case-control Study of Antiviral Therapy During Entire and the Third Trimester of Pregnancy in Preventing MTCT of HBV in Mothers With High Serum HBV DNA Load
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2018
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 19 Jul 2018 New trial record
- 01 Nov 2017 Status changed from recruiting to completed, as per the results published in the Journal of Viral Hepatitis